View in EDS

Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.

Saved in:
Bibliographic Details
Title: Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
Authors: Golding SE; Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA 23298-0058, USA., Rosenberg E, Valerie N, Hussaini I, Frigerio M, Cockcroft XF, Chong WY, Hummersone M, Rigoreau L, Menear KA, O'Connor MJ, Povirk LF, van Meter T, Valerie K
Source: Molecular cancer therapeutics [Mol Cancer Ther] 2009 Oct; Vol. 8 (10), pp. 2894-902. Date of Electronic Publication: 2009 Oct 06.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 19808981
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Golding+SE%22">Golding SE</searchLink>; Department of Radiation Oncology, Virginia Commonwealth University, Richmond, VA 23298-0058, USA.<br /><searchLink fieldCode="AU" term="%22Rosenberg+E%22">Rosenberg E</searchLink><br /><searchLink fieldCode="AU" term="%22Valerie+N%22">Valerie N</searchLink><br /><searchLink fieldCode="AU" term="%22Hussaini+I%22">Hussaini I</searchLink><br /><searchLink fieldCode="AU" term="%22Frigerio+M%22">Frigerio M</searchLink><br /><searchLink fieldCode="AU" term="%22Cockcroft+XF%22">Cockcroft XF</searchLink><br /><searchLink fieldCode="AU" term="%22Chong+WY%22">Chong WY</searchLink><br /><searchLink fieldCode="AU" term="%22Hummersone+M%22">Hummersone M</searchLink><br /><searchLink fieldCode="AU" term="%22Rigoreau+L%22">Rigoreau L</searchLink><br /><searchLink fieldCode="AU" term="%22Menear+KA%22">Menear KA</searchLink><br /><searchLink fieldCode="AU" term="%22O'Connor+MJ%22">O'Connor MJ</searchLink><br /><searchLink fieldCode="AU" term="%22Povirk+LF%22">Povirk LF</searchLink><br /><searchLink fieldCode="AU" term="%22van+Meter+T%22">van Meter T</searchLink><br /><searchLink fieldCode="AU" term="%22Valerie+K%22">Valerie K</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101132535%22">Molecular cancer therapeutics</searchLink> [Mol Cancer Ther] 2009 Oct; Vol. 8 (10), pp. 2894-902. <i>Date of Electronic Publication: </i>2009 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%2C+Inc%22">American Association for Cancer Research, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101132535 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1538-8514 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215357163%22">15357163 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=19808981
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1535-7163.MCT-09-0519
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2894
    Titles:
      – TitleFull: Improved ATM kinase inhibitor KU-60019 radiosensitizes glioma cells, compromises insulin, AKT and ERK prosurvival signaling, and inhibits migration and invasion.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Golding SE
      – PersonEntity:
          Name:
            NameFull: Rosenberg E
      – PersonEntity:
          Name:
            NameFull: Valerie N
      – PersonEntity:
          Name:
            NameFull: Hussaini I
      – PersonEntity:
          Name:
            NameFull: Frigerio M
      – PersonEntity:
          Name:
            NameFull: Cockcroft XF
      – PersonEntity:
          Name:
            NameFull: Chong WY
      – PersonEntity:
          Name:
            NameFull: Hummersone M
      – PersonEntity:
          Name:
            NameFull: Rigoreau L
      – PersonEntity:
          Name:
            NameFull: Menear KA
      – PersonEntity:
          Name:
            NameFull: O'Connor MJ
      – PersonEntity:
          Name:
            NameFull: Povirk LF
      – PersonEntity:
          Name:
            NameFull: van Meter T
      – PersonEntity:
          Name:
            NameFull: Valerie K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2009 Oct
              Type: published
              Y: 2009
          Identifiers:
            – Type: issn-electronic
              Value: 1538-8514
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Molecular cancer therapeutics
              Type: main
ResultId 1